Supplemental data 3. by Zachary J. Hough (20840430)

Subjects:

Morphological Degradation of Oxygen Evolution Reaction-Electrocatalyzing Nickel Selenides at Industrially Relevant Current Densities by Felix Hiege (21700895)

Subjects:

Pharmacological induction of mitochondrial dysfunction results in micronuclei and nuclear blebbing. by Zachary J. Hough (20840430)

Subjects:

Akt3 depletion results in micronuclei formation. by Zachary J. Hough (20840430)

Subjects:

Morphological Degradation of Oxygen Evolution Reaction-Electrocatalyzing Nickel Selenides at Industrially Relevant Current Densities by Felix Hiege (21700895)

Subjects:

Morphological Degradation of Oxygen Evolution Reaction-Electrocatalyzing Nickel Selenides at Industrially Relevant Current Densities by Felix Hiege (21700895)

Subjects:

Inequality measures of adolescent fertility rates in Sierra Leone, 2008–2019. by Augustus Osborne (15249788)

Subjects:

Akt3 null animals have reduced Aurora B expression and proliferation and increased apoptosis. by Zachary J. Hough (20840430)

Subjects:

Mitotic catastrophe is dependent on CRM-1 dysregulation. by Zachary J. Hough (20840430)

Subjects:

Trends in adolescent fertility rates in Sierra Leone by different inequality dimensions, 2008–2019. by Augustus Osborne (15249788)

Subjects:

Morphometric analysis of wild type and Akt3 null hearts. by Zachary J. Hough (20840430)

Subjects:

WDR12 associates with Aurora B. by Zachary J. Hough (20840430)

Subjects:

Model of the role of increased ROS in chromosome missegregation. by Zachary J. Hough (20840430)

Subjects:

ROS reduces the expression of Akt3, WDR12 and Aurora B leading to micronuclei. by Zachary J. Hough (20840430)

Subjects:

Akt3 controls the expression of WDR12, a chromosome binding protein. by Zachary J. Hough (20840430)

Subjects:

Image 6_Burden of pulmonary arterial hypertension in children globally, regionally, and nationally (1990–2021): results from the global burden of disease study.tif by Lili Deng (152262)

“…Significantly, reductions were observed in both mortality and disability-adjusted life years (DALYs) associated with pediatric PAH, with mortality decreasing by 57.66% and DALYs by 63.59% over the study period, indicating progress in mitigating the disease burden. …”

Image 3_Burden of pulmonary arterial hypertension in children globally, regionally, and nationally (1990–2021): results from the global burden of disease study.tif by Lili Deng (152262)

“…Significantly, reductions were observed in both mortality and disability-adjusted life years (DALYs) associated with pediatric PAH, with mortality decreasing by 57.66% and DALYs by 63.59% over the study period, indicating progress in mitigating the disease burden. …”

Image 1_Burden of pulmonary arterial hypertension in children globally, regionally, and nationally (1990–2021): results from the global burden of disease study.tif by Lili Deng (152262)

“…Significantly, reductions were observed in both mortality and disability-adjusted life years (DALYs) associated with pediatric PAH, with mortality decreasing by 57.66% and DALYs by 63.59% over the study period, indicating progress in mitigating the disease burden. …”

Table 2_Burden of pulmonary arterial hypertension in children globally, regionally, and nationally (1990–2021): results from the global burden of disease study.docx by Lili Deng (152262)

“…Significantly, reductions were observed in both mortality and disability-adjusted life years (DALYs) associated with pediatric PAH, with mortality decreasing by 57.66% and DALYs by 63.59% over the study period, indicating progress in mitigating the disease burden. …”

Table 4_Burden of pulmonary arterial hypertension in children globally, regionally, and nationally (1990–2021): results from the global burden of disease study.docx by Lili Deng (152262)

“…Significantly, reductions were observed in both mortality and disability-adjusted life years (DALYs) associated with pediatric PAH, with mortality decreasing by 57.66% and DALYs by 63.59% over the study period, indicating progress in mitigating the disease burden. …”